recombinant human apoe3 (R&D Systems)
Structured Review
Recombinant Human Apoe3, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 15 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+recombinant+apoe3/Recombinant+Human+Apolipoprotein+E3+Protein%2C+CF/bio_rxiv__64898__2026__02__05__704054-92-14-18
Average 94 stars, based on 15 article reviews
Images
Related Articles
Saline:Article Title: Decreased Expression of Hepatic Low-Density Lipoprotein Receptor–Related Protein 1 in Hypothyroidism: A Novel Mechanism of Atherogenic Dyslipidemia in Hypothyroidism Article Snippet: .. After 48 hours of T3 treatment, cells were washed once with phosphate buffered saline, and then incubated with 25 μg/mL Incubation:Article Title: Decreased Expression of Hepatic Low-Density Lipoprotein Receptor–Related Protein 1 in Hypothyroidism: A Novel Mechanism of Atherogenic Dyslipidemia in Hypothyroidism Article Snippet: .. After 48 hours of T3 treatment, cells were washed once with phosphate buffered saline, and then incubated with 25 μg/mL Article Title: Upregulation of hepatic LRP1 by rosiglitazone: a possible novel mechanism of the beneficial effect of thiazolidinediones on atherogenic dyslipidemia Article Snippet: .. After 48 h, cells were washed once with PBS and then incubated with 25 mg/ml Recombinant:Article Title: Decreased Expression of Hepatic Low-Density Lipoprotein Receptor–Related Protein 1 in Hypothyroidism: A Novel Mechanism of Atherogenic Dyslipidemia in Hypothyroidism Article Snippet: .. After 48 hours of T3 treatment, cells were washed once with phosphate buffered saline, and then incubated with 25 μg/mL Article Title: Upregulation of hepatic LRP1 by rosiglitazone: a possible novel mechanism of the beneficial effect of thiazolidinediones on atherogenic dyslipidemia Article Snippet: .. After 48 h, cells were washed once with PBS and then incubated with 25 mg/ml |

